Decreased ADAMTS13 Levels in Patients after Living Donor Liver Transplantation

Thrombosis Research

Volumn 124, Issue 5, 2009, Pages 541-545

  Kobayashi, Toshihiko ^a   Wada, Hideo ^a   Usui, Masanobu ^a   Sakurai, Hiroyuki ^a   Matsumoto, Takeshi ^a   Nobori, Tsutomu ^a   Katayama, Naoyuki ^a   Uemoto, Sinji ^b   Ishizashi, Hiromichi ^c   Matsumoto, Masanori ^c   Fujimura, Yoshihiro ^c   Isaji, Shuji ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

ADAMTS13; Liver transplantation; TMA; Von Willebrand factor

Indexed keywords

HEMOGLOBIN; LACTATE DEHYDROGENASE; POLYMER; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; AGED; ARTICLE; ERYTHROCYTE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOLYTIC ANEMIA; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC MICROANGIOPATHY LIKE SYNDROME; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; AGED; CHILD; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; THROMBOTIC MICROANGIOPATHIES; VON WILLEBRAND FACTOR;

EID: 70349859910     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.03.010     Document Type: Article

References (35)

1. Elliott M.A., and Nichols W.L. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Mayo Clin Proc 76 (2001) 1154-1162
2. Moake J.L. Thrombotic microangiopathies. N Engl J Med 347 (2002) 589-600
3. Banno S., Ito Y., Tanaka C., Hori T., Fujimoto K., Suzuki T., et al. Quantification of red blood cell fragmentation by the automated hematology analyzer XE-2100 in patients with living donor liver transplantation. Clin Lab Haematol 27 (2005) 292-296
4. Pettitt A.R., and Clark R.E. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 14 (1994) 495-504
5. Bukowski R.M. Thrombotic thrombocytopenic purpura; a review. Prog Hemost Thromb 6 (1982) 287-337
6. Humar A., Jessurun J., Sharp H.L., and Gruessner R.W. Hemolytic uremic syndrome in small-bowel transplant recipients; the first two case reports. Transpl Int 12 (1999) 387-390
7. Trimarchi H.M., Truong L.D., Brennan S., Gonzalez J.M., and Suki W.N. FK506-associated thrombotic microangiopathy; report of two cases and review of the literature. Transplantation 67 (1999) 539-544
8. Miyata R., Shimazu M., Tanabe M., Kawachi S., Hoshino K., Wakabayashi G., et al. Clinical characteristics of thrombotic microangiopathy following ABO incompatible living donor liver transplantation. Liver Transpl 13 (2007) 1455-1462
9. Bonser R.S., Adu D., Franklin I., and McMaster P. Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient. Lancet 2 (1984) 1337
10. Holman M.J., Gonwa T.A., Cooper B., Husberg B.S., Goldstein R.M., Gibbs J.F., et al. FK506-associated thrombotic thrombocytopenic purpura. Transplantation 55 (1993) 205-206
11. Rerolle J.P., Akposso K., Lerolle N., Mougenot B., Ponnelle T., Rondeau E., et al. Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation. Clin Transplant 14 (2000) 262-265
12. Singh N., Gayowski T., and Marino I.R. Hemolytic uremic syndrome in solid-organ transplant recipients. Transpl Int 9 (1996) 68-75
13. Ramasubbu K., Mullick T., Koo A., Hussein M., Henderson J.M., Mullen K.D., et al. Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based review. Transpl Infect Dis 5 (2003) 98-103
14. Tamura S., Sugawara Y., Matsui Y., Kishi Y., Akamatsu N., Kaneko J., et al. Thrombotic microangiopathy in living-donor liver transplantation. Transplantation 80 (2005) 169-175
15. Ko S., Okano E., Kanehiro H., Matsumoto M., Ishizashi H., Uemura M., et al. Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: observations in 3 cases. Liver Transpl 12 (2006) 859-869
16. Soejima K., Mimura N., Hirashima M., Maeda H., Hamamoto T., Nakagaki T., et al. A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor- cleaving protease?. J Biochem 130 (2001) 475-480
17. Levy G.G., Nichols W.C., Lian E.C., Foroud T., McClintick J.N., McGee B.M., et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpula. Nature 413 (2001) 488-494
18. Zheng X., Chung D., Takayama T.K., Majerus E.M., Sadler J.E., and Fujikawa K. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 276 (2001) 41059-41063
19. Fujikawa K., Suzuki H., McMullen B., and Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 98 (2001) 1662-1666
20. Gerritsen H.E., Robles R., Lammle B., and Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 98 (2001) 1654-1661
21. Kokame K., Matsumoto M., Soejima K., Yagi H., Ishizashi H., Funato M., et al. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proc Natl Acad Sci USA 99 (2002) 11902-11907
22. Moake J.L., Rudy C.K., Troll J.H., Weinstein M.J., Colannino N.M., Azocar J., et al. Unusually large plasma factor VIII; von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307 (1982) 1432-1435
23. Chow T.W., Turner N.A., Chintagumpala M., McPherson P.D., Nolasco L.H., Rice L., et al. Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura. Am J Hematol 57 (1998) 293-302
24. Ruggeri Z.M. Structure and function of von Willebrand factor. Thromb Haemost 82 (1999) 576-584
25. Kokame K., Nobe Y., Kokubo Y., Okayama A., and Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 129 (2005) 93-100
26. Ruggeri Z.M., and Zimmerman T.S. Variant von Willebrand's disease; Characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willenrand factor in plasma and platelets. J Clin Invest 65 (1980) 1318-1325
27. Budde U., Schneppenheim R., Plendl H., Dent J., Ruggeri Z.M., and Zimmerman T.S. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost 63 (1990) 312-315
28. Abe Y., Wada H., Tomatsu H., Sakaguchi A., Nishioka J., Yabu Y., et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res 118 (2006) 463-469
29. Matsumoto M., Yagi H., Ishizashi H., Wada H., and Fujimura Y. The Japansese experience with thrombotic thrombocytopenic purpura - Hemolytic uremic syndrome. Semin Hematol 41 (2004) 68-74
30. Mannucci P.M., Capoferri C., and Canciani M.T. Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease. Br J Haematol 126 (2004) 213-218
31. Park Y.D., Yoshioka A., Kawa K., Ishizashi H., Yagi H., Yamamoto Y., et al. Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation. Bone Marrow Transplant 29 (2002) 789-794
32. Schlanger R.E., Henry M.L., Sommer B.G., and Ferguson R.M. Identification and treatment of cyclosporine-associated allograft thrombosis. Surgery 100 (1986) 329-333
33. Venkat K.K., Tkach D., Kupin W., Mozes M., Oh H.K., Raman B.K., et al. Reversal of cyclosporine-associated hemolytic-uremic syndrome by plasma exchange with fresh-frozen plasma replacement in renal transplant recipients. Transplant Proc 23 (1991) 1256-1257
34. Sekido H., Matsuo K., Takeda K., Morioka D., Kubota T., Tanaka K., et al. Successful adult ABO-incompatible liver transplantation; therapeutic strategy for thrombotic microangiopathy is the key to success. Transplantation 75 (2003) 1605-1607
35. Nakazawa Y., Hashikura Y., Urata K., Ikegami T., Terada M., Yagi H., et al. Von Willebrand factor-cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: a case report. Liver Transpl 9 (2003) 1328-1333